DATATRAK International, Inc. (DTRK)
- Previous Close
0.5500 - Open
0.4610 - Bid --
- Ask --
- Day's Range
0.5500 - 0.5500 - 52 Week Range
0.0100 - 0.6200 - Volume
214 - Avg. Volume
3,290 - Market Cap (intraday)
3.119M - Beta (5Y Monthly) 1.93
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Apr 26, 1995
- 1y Target Est
8.00
DATATRAK International, Inc., a technology and services company, provides unified clinical solutions and related services for the clinical trials industry. The company offers DATATRAK ONE Unified Experience, a clinical enterprise solution that allows clinical users and service providers to design, deliver, and manage clinical trials. Its products include UX CTMS 360 for planning and managing trials; UX Trial to streamline design-to-deployment process using a tool; UX EDC & Medical Coding for capturing and delivering data; UX Randomization and Trial Supply Management to randomize patients and automate supply; UX Patient Data Capture; UX Safety; and UX Training to train users and track certificates. The company also provides DATATRAK Clinical Consulting Services, such as training, support, learning center, Software as a Service hosting, standards, and trial design services. It serves contract research organizations, pharma and biotech companies, and clinical trial device companies. DATATRAK International, Inc. was founded in 1991 and is headquartered in Mayfield Heights, Ohio.
www.datatrak.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: DTRK
Performance Overview: DTRK
Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DTRK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DTRK
Valuation Measures
Market Cap
3.12M
Enterprise Value
3.12M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.11%
Return on Assets (ttm)
-8.00%
Return on Equity (ttm)
-0.50%
Revenue (ttm)
6.5M
Net Income Avi to Common (ttm)
-7.01k
Diluted EPS (ttm)
-0.1200
Balance Sheet and Cash Flow
Total Cash (mrq)
1.83M
Total Debt/Equity (mrq)
87.91%
Levered Free Cash Flow (ttm)
--
Research Analysis: DTRK
Company Insights: DTRK
DTRK does not have Company Insights